Clin Assess
For more than 22 years, Clin Assess is a CRO that pursue its work with great passion. They work on commercial studies including those with a high patient number.
Customers appreciate their medical background, their expertise, and the precision in which they achieve their goals and realise all phases of the clinical trial with pinpoint accuracy.
They rely on clear project communication with interactive feedback, provide individual support for their customers and accompany them step by step from the beginning and through all stages of the project.
Their employees are specialists from the pharmaceutical industry, contract research and the clinical sector. They have special expertise in the fields of oncology, cardiovascular diseases, infectious diseases, immunotherapy, personalised medicine and diseases of the central nervous system.
Learn more: www.clinassess.de
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
February 26, 2026
During the EUCROF 2026 gala dinner in Amsterdam, in front of 300+ participants from the European clinical research ecosystem, the xShare project Open Call Awards for Clinical Research were officially presented. We are extremely proud that Telemedicine Technologies contributed to three complementary xShare Open Call projects (out of 10), all recognised for their quality, innovation […]
January 29, 2026
Medtech Dive Amid a deregulatory push by the Trump administration, the Food and Drug Administration is scrutinizing its digital health policies. The agency suddenly issued a pair of guidances earlier this month, intended to clarify its approach to wellness devices and medical software. The updates reflect changes to the agency’s thinking about what counts as a wellness […]
January 29, 2026
Med City News The Covid-19 pandemic impacted virtually every industry, with healthcare arguably undergoing the most drastic transformation. Pre-pandemic, most of us never could’ve imagined routine doctor visits happening over telehealth, or a brand-new vaccine being developed, tested, and authorized for emergency use in under a year. The urgency of the pandemic forced medical scientists […]